Two Dosage form of same ayurvedic drug & to evaluate their Comparative Stability & effect on Dadru (Skin Disease)

Pharmaceutical Modification of Dadrughni Vati(Lepa) into Malhara & to evaluate their Comparative Stability Study & Clinical Efficacy on Dadru - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055376

Enrollment

Registered

2023-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion based on classical sign and symptoms of Dadru fulfilling the diagnostic criteria

Exclusion criteria

Exclusion criteria: Age 60 yrs Patients suffering with systemic disease like Diabetes, Hypertension, Malignancy, Tuberculosis, Renal disease, Liver Disease, VDRL +ve cases etc.

Design outcomes

Primary

Measure	Time frame
Difference in the classical symptoms Pidika (Eruption per Mandala) Utsanna Mandala(Number of Slightly Elevated from Skin surface patch) Utsanna Mandala(Size of Slightly Elevated from Skin surface patch)Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Difference in the classical symptoms Kandu (Itching), Raga ( Redness)Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Bharat D. Kalsariya

Government Ayurved College,Vadodara

drbharat1977@gmail.com8141854828

Outcome results